The human kallikrein 10 promoter contains a functional retinoid response element

References

Astrom, A., Pettersson, U., Chambon, P., and Voorhees, J.J. (1994). Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. J. Biol. Chem.269, 22334–22339.10.1016/S0021-9258(17)31794-5Search in Google Scholar

Band, V., Zajchowski, D., Swisshelm, K., Trask, D., Kulesa, V., Cohen, C., Connolly, J., and Sager, R. (1990). Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res.50, 7351–7357.Search in Google Scholar

Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar PubMed

Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res.2, 257–280.10.1158/1541-7786.257.2.5Search in Google Scholar

Cleutjens, K.B., van der Korput, H.A., van Eekelen, C.C., van Rooij, H.C., Faber, P.W., and Trapman, J. (1997). An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol.11, 148–161.10.1210/mend.11.2.9883Search in Google Scholar PubMed

Coradini, D. and Daidone, M.G. (2004). Biomolecular prognostic factors in breast cancer. Curr. Opin. Obstet. Gynecol.16, 49–55.10.1097/00001703-200402000-00010Search in Google Scholar PubMed

Dhar, S., Bhargava, R., Yunes, M., Li, B., Goyal, J., Naber, S.P., Wazer, D.E., and Band, V. (2001). Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin. Cancer Res.7, 3393–3398.Search in Google Scholar

Dimri, G., Band, H., and Band, V. (2005). Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res.7, 171–179.10.1186/bcr1275Search in Google Scholar PubMed PubMed Central

Goyal, J., Smith, K.M., Cowan, J.M., Wazer, D.E., Lee, S.W., and Band, V. (1998). The role for NES1 serine protease as a novel tumor suppressor. Cancer Res.58, 4782–4786.Search in Google Scholar

Lewis, B.A. and Reinberg, D. (2003). The mediator coactivator complex: functional and physical roles in transcriptional regulation. J. Cell Sci.116, 3667–3675.10.1242/jcs.00734Search in Google Scholar PubMed

Li, B., Goyal, J., Dhar, S., Dimri, G., Evron, E., Sukumar, S., Wazer, D.E., and Band, V. (2001). CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res.61, 8014–8021.Search in Google Scholar

Liu, X.L., Wazer, D.E., Watanabe, K., and Band, V. (1996). Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res.56, 3371–3379.Search in Google Scholar

Luo, L.Y., Grass, L., and Diamandis, E.P. (2003). Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter. Clin. Chim. Acta337, 115–126.10.1016/j.cccn.2003.07.008Search in Google Scholar PubMed

Magklara, A., Brown, T.J., and Diamandis, E.P. (2002). Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. Int. J. Cancer100, 507–514.10.1002/ijc.10520Search in Google Scholar PubMed

Meng, G., Zhao, Y., Nag, A., Zeng, M., Dimri, G., Gao, Q., Wazer, D.E., Kumar, R., Band, H., and Band, V. (2004). Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation. J. Biol. Chem.279, 54230–54240.10.1074/jbc.M404482200Search in Google Scholar PubMed

Pelzer, A.E., Volgger, H., Bektic, J., Berger, A.P., Rehder, P., Bartsch, G., and Horninger, W. (2005). The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels. BJU Int.96, 995–998.10.1111/j.1464-410X.2005.05800.xSearch in Google Scholar

Ramharack, R., Wyborski, R.J., and Spahr, M.A. (1998). The apolipoprotein(a) promoter contains a retinoid response element. Biochem. Biophys. Res. Commun.245, 194–197.10.1006/bbrc.1998.8398Search in Google Scholar

Rastinejad, F. (2001). Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struct. Biol.11, 33–38.10.1016/S0959-440X(00)00165-2Search in Google Scholar

Sidiropoulos, M., Pampalakis, G., Sotiropoulou, G., Katsaros, D., and Diamandis, E.P. (2005). Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Tumour Biol.26, 324–336.10.1159/000089290Search in Google Scholar

Stewart, A.J., Scher, H.I., Chen, M.H., McLeod, D.G., Carroll, P.R., Moul, J.W., and D'Amico, A.V. (2005). Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J. Clin. Oncol.23, 6556–6560.10.1200/JCO.2005.20.966Search in Google Scholar

Wazer, D.E., Chu, Q., Liu, X.L., Gao, Q., Safaii, H., and Band, V. (1994). Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol. Cell. Biol.14, 2468–2478.Search in Google Scholar

Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R.A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell117, 927–939.10.1016/j.cell.2004.06.006Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev.22, 184–204.Search in Google Scholar

Yousef, G.M., Scorilas, A., Kyriakopoulou, L.G., Rendl, L., Diamandis, M., Ponzone, R., Biglia, N., Giai, M., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002). Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin. Chem.48, 1241–1250.10.1093/clinchem/48.8.1241Search in Google Scholar

Yousef, G.M., Scorilas, A., Katsaros, D., Fracchioli, S., Iskander, L., Borgono, C., Rigault de la Longrais, I.A., Puopolo, M., Massobrio, M., and Diamandis, E.P. (2003). Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J. Clin. Oncol.21, 3119–3126.10.1200/JCO.2003.09.111Search in Google Scholar

Yousef, G.M., Obiezu, C.V., Luo, L.Y., Magklara, A., Borgono, C.A., Kishi, T., Memari, N., Michael, P., Sidiropoulos, M., Kurlender, L., et al. (2005). Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem.39, 11–79.10.1016/S0065-2423(04)39002-5Search in Google Scholar

Yunes, M.J., Neuschatz, A.C., Bornstein, L.E., Naber, S.P., Band, V., and Wazer, D.E. (2003). Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery. Int. J. Radiat. Oncol. Biol. Phys.56, 653–657.10.1016/S0360-3016(03)00068-3Search in Google Scholar

Zeng, M., Kumar, A., Meng, G., Gao, Q., Dimri, G., Wazer, D., Band, H., and Band, V. (2002). Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator. J. Biol. Chem.277, 45611–45618.10.1074/jbc.M208447200Search in Google Scholar PubMed